STAMFORD, Conn.--(BUSINESS WIRE)--FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that its Synapse PACS line has been granted Authority to Operate (ATO) on networks in the U.S. Department of Defense (DoD), making Fujifilm the first vendor with a networked medical system to attain a Risk Management Framework (RFM)-based ATO.
“This particular ATO is an unprecedented achievement in that our technology had to stand up to the rigors of a brand new risk management framework process recently implemented by the Department of Defense,” said Johann Fernando, Ph.D, Chief Operating Officer, FUJIFILM Medical Systems U.S.A., Inc. “The fact that Fujifilm is the very first vendor to meet these new challenges speaks to our unrivalled history of innovation, flexibility and stringent security standards.”
In the past year, the DoD transitioned from its traditional DIACAP process to a new RMF process for evaluating technologies and determining ATO status. The new process contains thousands of changes and generally takes over a year to complete.
The Risk Management Framework provides a process that integrates security and risk management activities into the system development life cycle. The risk-based approach to security control selection and specification considers effectiveness, efficiency, and constraints due to applicable laws, directives, Executive Orders, policies, standards, or regulations.
After completing a thorough security assessment, the DoD determined that Fujifilm’s Synapse PACS line meets its controls for RMF including the DoD 8500 Series controls and the Security and Technical Implementation Guides (STIG) requirements. The new ATO granted to Fujifilm is valid until March 2020.
“This latest ATO from the Department of Defense is testimony to the fact that risk mitigation remains a top priority at Fujifilm,” said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “We look forward to our continued strong relationship with the DoD.”
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.